Capsaicin-induced inhibition of platelet aggregation is not mediated by transient receptor potential vanilloid type 1

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 1, 2012, Pages 94-97

  Mittelstadt, Scott W ^a   Nelson, Richard A ^a   Daanen, Jerome F ^b   King, Andrew J ^a   Kort, Michael E ^b   Kym, Philip R ^b   Lubbers, Nathan L ^a   Cox, Bryan F ^a   Lynch III, James J ^a  

^a Department of Integrative Pharmacology ^*  (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

A 993610; blood; capsaicin; collagen; dogs; platelet aggregation; transient receptor potential vanilloid type 1

Indexed keywords

A 993610; CAPSAICIN; COLLAGEN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; INCUBATION TIME; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

ANIMALS; CAPSAICIN; DOGS; MALE; PLATELET AGGREGATION; TRPV CATION CHANNELS;

EID: 84855188309     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834ddf18     Document Type: Article

References (15)

1. Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 2007; 6:357-372. (Pubitemid 46705200)
2. Jancsó G, Kiraly E, Jancsó -Gábor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature 1977; 270:741-743. (Pubitemid 8239254)
3. Starowicz K, Nigam S, Di Marzo V. Biochemistry and pharmacology of endovanilloids. Pharmacol Ther 2007; 114:13-33. (Pubitemid 46498161)
4. Wang J-P, Hsu M-F, Hsu T-P, Teng C-M. Antihemostatic and antithrombotic effects of capsaicin in comparison with aspirin and indomethacin. Thromb Res 1985; 37:669-679.
5. Hogaboam CM, Wallace JL. Inhibition of platelet aggregation by capsaicin: An effect unrelated to actions on sensory afferent neurons. Eur J Pharmacol 1991; 202:129-131.
6. Wang J-P, Hsu M-F, Teng C-M. Antiplatelet effect of capsaicin. Thromb Res 1984; 36:497-507. (Pubitemid 15191577)
7. Adams MJ, Ahuja KDK, Geraghty DP. Effect of capsaicin and dihydrocapsaicin on in vitro blood coagulation and platelet aggregation. Thromb Res 2009; 124:721-723.
8. Raghavendra RH, Naidu KA. Spice active principles as the inhibitors of human platelet aggregation and thromboxane biosynthesis. Prostaglandins Leukot Essent Fatty Acids 2009; 81:73-78.
9. Sylvester DM, LaHann TR. Effects of capsaicinoids on platelet aggregation. Proc West Pharmacol Soc 1989; 32:95-100. (Pubitemid 19189183)
10. Harper AGS, Brownlow SL, Sage SO. A role for TRPV1 in agonist-evoked activation of human platelets. J Thromb Haemost 2009; 7:330-338.
11. Honore P, Chandran P, Hernandez G, Gauvin DM, Mikusa JP, Zhong C, et al. Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia. Pain 2009; 142:27-35.
12. Meddings JB, Hogaboam CM, Tran K, Reynolds JD, Wallace JL. Capsaicin effects on nonneuronal plasma membranes. Biochim Biophys Acta 1991; 1070:43-50.
13. Rizvi SI, Luqman S. Capsaicin-induced activation of erythrocyte membrane sodium/potassium and calcium adenosine triphosphatases. Cell Mol Biol Lett 2003; 8:919-925. (Pubitemid 38095068)
14. Aranda FJ, Villalaín J, Gó mez-Fernández JC. Capsaicin affects the structure and phase organization of phospholipid membranes. Biochim Biophys Acta 1995; 1234:225-234.
15. Tsuchiya H. Biphasic membrane effects of capsaicin, an active component in Capsicum species. J Ethnopharmacol 2001; 75:295-299. (Pubitemid 32297749)